Maynard Um
-
-
-
-
-
-
-
Raymond James on Dianthus Therapeutics (DNTH) Amid 15% Down Day: 'We See Overall Positive Readthrough to Claseprubart'
-
-
-
-
-
-
-
Sanofi climbs as strong Dupixent sales drive Q1 revenue and profit beat
-
-
-
-
-
-
-
DNDi and Sanofi drug receives CHMP positive opinion for sleeping sickness
-
-
-
-
-
-
-
UBS Downgrades Sanofi (SAN:FP) (SNY) to Neutral
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Sanofi (SNY)
-
-
-
-
-
-
-
Sanofi reaches deal with US government to cut drug prices
-
-
-
-
-
-
-
Novavax completes US marketing transfer to Sanofi, receives $25 million
-
431,647 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

